United States Non-Invasive Prenatal Testing Market 2019 – 2026

$ 1,500$ 2,500

Published Date: July, 2019

Content info: 120 pages

Region: United States

Published By: DPI Research

Clear

The United States Non-Invasive Prenatal Testing market will register a robust CAGR of more than 13% by 2026.

United States Non-Invasive Prenatal Testing Market 2019 – 2026 presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. The report offers the most up–to–date industry data on the actual market situation and future outlook in the United States Non-Invasive Prenatal Testing market. The report includes historical data from 2015 – 2018 and forecasts until 2026.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, NIPT test volume, revenues and provides forecasts through 2026. The report also includes an assessment of comparative test analysis by companies. It also covers reimbursement pattern and offers a clear view of the regulatory landscape in the United States Non–Invasive Prenatal Testing market. Key trends in terms of collaboration deals, partnerships, merger & acquisitions, venture capital investment, distribution, and licensing agreement are analyzed with details. The report also explores the detailed description of market drivers and inhibitors of the United States Non–Invasive Prenatal Testing market.

The report concludes with the profiles of major players in the United States Non–Invasive Prenatal Testing market. The key market players are evaluated on various parameters such as business overview, product outlook, and key development in the non–invasive prenatal testing market.

Key Topics Covered in the Report are as follows:

  • The United States Non–Invasive Prenatal Testing (NIPT) Market Size & Future Trends (2015 – 2026)
  • The United States Non–Invasive Prenatal Testing (NIPT) Market Opportunity Assessment (2015 – 2026)
  • The United States Average Risk Non–Invasive Prenatal Testing (NIPT) Market Size & Future Trends (2015 – 2026)
  • The United States High-Risk Non–Invasive Prenatal Testing (NIPT) Market Size & Future Trends (2015 – 2026)
  • The United States Average Risk Potential Non–Invasive Prenatal Testing (NIPT) Market Size & Future Trends (2015 – 2026)
  • The United States High-Risk Potential Non–Invasive Prenatal Testing (NIPT) Market Size & Future Trends (2015 – 2026)
  • The United States Average Risk Non–Invasive Prenatal Testing (NIPT) Volume (Number of Tests Performed) & Future Trends (2015 – 2026)
  • The United States High-Risk Non–Invasive Prenatal Testing (NIPT) Volume (Number of Tests Performed) & Future Trends (2015 – 2026)
  • The United States Average Risk Potential Non–Invasive Prenatal Testing (NIPT) Volume (Number of Tests Performed) & Future Trends (2015 – 2026)
  • The United States High-Risk Potential Non–Invasive Prenatal Testing (NIPT) Volume (Number of Tests Performed) & Future Trends (2015 – 2026)
  • Non–Invasive Prenatal Testing Comparative Analysis – By Test
  • Reimbursement Policies of the United States Non-Invasive Prenatal Testing
  • Regulation System of the United States Non-Invasive Prenatal Testing
  • Major Deals in the Non–Invasive Prenatal Testing Market
  • United States Non–Invasive Prenatal Testing Market Drivers and Inhibitors
  • Key Companies Analysis

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

  • Illumina
  • Natera
  • Quest Diagnostics
  • Myriad Genetics
  • Centogene
  • Invitae Corporation
  • GenPath
  • Progenity
  • PerkinElmer
  • Agilent Technologies
  • Integrated Genetics (LabCorp)
  • Ariosa Diagnostics (Roche)
CHOOSE YOUR BUYING OPTION

Multi User Price, Single User Price

Table of Contents

1. Executive Summary

2. United States Non-Invasive Prenatal Testing(NIPT) Market Size & Analysis (2015 – 2026) 
2.1 Total Actual NIPT Test Volume (Number of Tests Performed) & Forecast (2015 – 2026) 
2.1.1 Average Risk Actual NIPT Test Volume (Number of Tests Performed) & Forecast (2015 – 2026) 
2.1.2 High-Risk Actual NIPT Test Volume (Number of Tests Performed) & Forecast (2015 – 2026) 

2.2 Total Actual NIPT Test Market Revenue & Forecast (2015 – 2026) 
2.2.1 Average Risk Actual NIPT Test Market Revenue & Forecast (2015 – 2026) 
2.2.2 High-Risk Actual NIPT Test Market Revenue & Forecast (2015 – 2026) 

3. United States Non-Invasive Prenatal Testing(NIPT) Market Opportunity Assessment (2015 – 2026) 
3.1 Total Potential NIPT Test Volume (Number of Tests Performed) & Forecast (2015 – 2026) 
3.1.1 Average Risk Potential NIPT Test Volume (Number of Tests Performed) & Forecast (2015 – 2026) 
3.1.2 High-Risk Potential NIPT Test Volume (Number of Tests Performed) & Forecast (2015 – 2026)

3.2 Total Potential NIPT Test Market Revenue & Forecast (2015 – 2026) 
3.2.1 Average Risk Potential NIPT Test Market Revenue & Forecast (2015 – 2026) 
3.2.2 High-Risk Potential NIPT Test Market Revenue & Forecast (2015 – 2026)

4. United States Non-Invasive Prenatal Testing Market Drivers and Inhibitors
4.1 Market Drivers
4.2 Market Inhibitors

5. Non-Invasive Prenatal Testing Comparative Analysis – By Test

6. Reimbursement Policies of the United States Non-Invasive Prenatal Testing

7. Regulation System of the United States Non-Invasive Prenatal Testing

8. Major Deals in the Non-Invasive Prenatal Testing Market
8.1 Collaboration Deals
8.2 Venture Capital Investment
8.3 Merger and Acquisition
8.4 Exclusive Agreement
8.5 Licensing Agreement
8.6 Distribution Agreement
8.7 Partnership Deals

9. Key Companies Analysis

9.1 Integrated Genetics (LabCorp) 
9.1.1 Business Overview
9.1.2 Product Outlook
9.1.3 Key Developments
9.2 Ariosa Diagnostics (Roche) 
9.2.1 Business Overview
9.2.2 Product Outlook
9.2.3 Key Developments
9.3 Illumina
9.3.1 Business Overview
9.3.2 Product Outlook
9.3.3 Key Developments
9.4 Natera
9.4.1 Business Overview
9.4.2 Product Outlook
9.4.3 Key Developments
9.5 Quest Diagnostics
9.5.1 Business Overview
9.5.2 Product Outlook
9.5.3 Key Developments
9.6 Myriad Genetics
9.6.1 Business Overview
9.6.2 Product Outlook
9.6.3 Key Developments
9.7 Centogene
9.7.1 Business Overview
9.7.2 Product Outlook
9.7.3 Key Developments
9.8 Invitae Corporation
9.8.1 Business Overview
9.8.2 Product Outlook
9.8.3 Key Developments
9.9 Otogenetics
9.9.1 Business Overview
9.9.2 Product Outlook
9.9.3 Key Developments
9.10 GenPath
9.10.1 Business Overview
9.10.2 Product Outlook
9.10.3 Key Developments
9.11 Progenity
9.11.1 Business Overview
9.11.2 Product Outlook
9.11.3 Key Developments
9.12 PerkinElmer
9.12.1 Business Overview
9.12.2 Product Outlook
9.12.3 Key Developments
9.13 Agilent Technologies
9.13.1 Business Overview
9.13.2 Product Outlook
9.13.3 Key Developments

List of Tables 

Table 4-1: Maternal Age at Delivery and Risk of Down Syndrome
Table 5-1: Non-Invasive Prenatal Testing – Comparative Tests Analysis
Table 6-1: NIPT Test CMS Price (US$),2017
Table 7-1: Collaboration Deals in the Non-Invasive Prenatal Testing Market
Table 7-2: Venture Capital Investment in the Non-Invasive Prenatal Testing Market
Table 7-3: Merger & Acquisition in the Non-Invasive Prenatal Testing Market
Table 7-4: Exclusive Agreement in the Non-Invasive Prenatal Testing Market
Table 7-5: Licensing Agreement in the Non-Invasive Prenatal Testing Market
Table 7-6: Distribution Agreement in the Non-Invasive Prenatal Testing Market
Table 7-7: Partnership Deals in the Non-Invasive Prenatal Testing Market

List of Figures 

Figure 2-1: United States Actual NIPT Test Volume (Thousand),2015 – 2018
Figure 2-2: United States Actual NIPT Test Volume Forecast (Thousand),2019 – 2026
Figure 2-3: United States Average Risk Actual NIPT Test Volume (Thousand),2015 – 2018
Figure 2-4: United States Average Risk Actual NIPT Test Volume Forecast (Thousand),2019 – 2025
Figure 2-5: United States High-Risk Actual NIPT Test Volume (Thousand),2015 – 2018
Figure 2-6: United States High-Risk Actual NIPT Test Volume Forecast (Thousand),2019 – 2026
Figure 2-7: United States Actual NIPT Test Market Revenue (Million US$),2015 – 2018
Figure 2-8: United States Actual NIPT Test Market Revenue Forecast (Million US$),2019 – 2026
Figure 2-9: United States Average Risk Actual NIPT Test Market Revenue (Million US$),2015 – 2018
Figure 2-10: United States Average Risk Actual NIPT Test Market Revenue Forecast (Million US$),2019 – 2026
Figure 2-11: United States High-Risk Actual NIPT Test Market Revenue (Million US$),2015 – 2018
Figure 2-12: United States High-Risk Actual NIPT Test Market Revenue Forecast (Million US$),2019 – 2026
Figure 3-1: United States Potential NIPT Test Volume (Thousand),2015 – 2018
Figure 3-2: United States Potential NIPT Test Volume Forecast (Thousand),2019 – 2026
Figure 3-3: United States Average Risk Potential NIPT Test Volume (Thousand),2015 – 2018
Figure 3-4: United States Average Risk Potential NIPT Test Volume Forecast (Thousand),2019 – 2026
Figure 3-5: United States High-Risk Potential NIPT Test Volume (Thousand),2015 – 2018
Figure 3-6: United States High-Risk Potential NIPT Test Volume Forecast (Thousand),2019 – 2026
Figure 3-7: United States Potential NIPT Test Market Revenue (Million US$),2015 – 2018
Figure 3-8: United States Potential NIPT Test Market Revenue Forecast (Million US$),2019 – 2026
Figure 3-9: United States Average Risk Potential NIPT Test Market Revenue (Million US$),2015 – 2018
Figure 3-10: United States Average Risk Potential NIPT Test Market Revenue Forecast (Million US$),2019 – 2026
Figure 3-11: United States High-Risk Potential NIPT Test Market Revenue (Million US$),2015 – 2018
Figure 3-12: United States High-Risk Potential NIPT Test Market Revenue Forecast (Million US$),2019 – 2026

Companies Mentioned

  • Illumina
  • Natera
  • Quest Diagnostics
  • Myriad Genetics
  • Centogene
  • Invitae Corporation
  • GenPath
  • Progenity
  • PerkinElmer
  • Otogenetics
  • Agilent Technologies
  • Integrated Genetics (LabCorp)
  • Ariosa Diagnostics (Roche)

Reviews

There are no reviews yet.

Be the first to review “United States Non-Invasive Prenatal Testing Market 2019 – 2026”

Your email address will not be published. Required fields are marked *